AIRLINK 74.39 Increased By ▲ 1.39 (1.9%)
BOP 5.37 Increased By ▲ 0.02 (0.37%)
CNERGY 4.35 Increased By ▲ 0.04 (0.93%)
DFML 27.75 Decreased By ▼ -0.80 (-2.8%)
DGKC 76.95 Increased By ▲ 2.66 (3.58%)
FCCL 20.40 Increased By ▲ 0.05 (0.25%)
FFBL 31.30 Increased By ▲ 0.40 (1.29%)
FFL 10.22 Increased By ▲ 0.16 (1.59%)
GGL 10.40 Increased By ▲ 0.01 (0.1%)
HBL 116.75 Increased By ▲ 0.78 (0.67%)
HUBC 135.61 Increased By ▲ 3.41 (2.58%)
HUMNL 6.70 Increased By ▲ 0.02 (0.3%)
KEL 4.19 Increased By ▲ 0.16 (3.97%)
KOSM 4.80 Increased By ▲ 0.20 (4.35%)
MLCF 38.97 Increased By ▲ 0.43 (1.12%)
OGDC 134.70 Increased By ▲ 0.85 (0.64%)
PAEL 23.69 Decreased By ▼ -0.14 (-0.59%)
PIAA 27.33 Increased By ▲ 0.20 (0.74%)
PIBTL 6.89 Increased By ▲ 0.13 (1.92%)
PPL 113.60 Increased By ▲ 0.80 (0.71%)
PRL 27.85 Decreased By ▼ -0.31 (-1.1%)
PTC 14.61 Decreased By ▼ -0.28 (-1.88%)
SEARL 56.80 Increased By ▲ 0.38 (0.67%)
SNGP 66.00 Increased By ▲ 0.20 (0.3%)
SSGC 11.05 Increased By ▲ 0.04 (0.36%)
TELE 9.08 Increased By ▲ 0.06 (0.67%)
TPLP 11.75 Decreased By ▼ -0.15 (-1.26%)
TRG 70.00 Increased By ▲ 0.90 (1.3%)
UNITY 23.75 Increased By ▲ 0.04 (0.17%)
WTL 1.33 No Change ▼ 0.00 (0%)
BR100 7,498 Increased By 64.2 (0.86%)
BR30 24,492 Increased By 271.9 (1.12%)
KSE100 72,103 Increased By 743.9 (1.04%)
KSE30 23,824 Increased By 256.7 (1.09%)

imageWASHINGTON: The White House joked Monday that a snorting Donald Trump may not be the best person to demand drug tests before the next presidential debate Wednesday.

White House spokesman Josh Earnest was asked about Trump's controversial claim that his rival Hillary Clinton was "pumped up" on performance-enhancing drugs in the previous debate.

Earnest responded with a barbed remark that alluded to Trump's repeated and very audible nasal activities at debate time.

"You're telling me the candidate who snorted his way through the first two debates is accusing the other candidate of taking drugs?"

Earnest said he was having some fun and not suggesting Trump is a drug user.

Copyright AFP (Agence France-Presse), 2016

Comments

Comments are closed.